思密达、洗胃治疗新生儿咽下综合征分析  

Comparison of the Therapeutic Effect Between Gastrolavage and Oral Smecta for Neonatal Swallowing Syndrome

作　　者：黎冬梅 周宁 叶家卫[2] 

机构地区：[1]广州市海珠区妇幼保健院,广东广州510250 [2]广州市儿童医院,广东广州510120

出　　处：《中国医药指南》2011年第22期32-32,共1页Guide of China Medicine

摘　　要：目的观察思密达治疗新生儿咽下综合征的疗效。方法 118例新生儿咽下综合征患儿随机分为治疗组(n=60)与对照组(n=58),治疗组接受思密达治疗,对照组接受1%碳酸氢钠洗胃治疗。结果治疗组与对照组总疗效相近,但治疗组服用简便,易为患儿接受。结论思密达治疗新生儿咽下综合征治疗方便、疗效显著、副作用小。Objective To compare the different therapeutic effect between gastrolavage and Smecta for neonatal swallowing syndrome.Methods 118 newborns with swallowing syndrome were randomly divided into study group（oral smecta,n=60） and control group（gastrolavage by sodium bicarbonate,n=58）.Results The therapeutic effect was similar between the study group and control group.Oral smecta was easier to use and more likely to be accepted than gastrolavage for the newborns.Conclusion In patients with neonatal swallowing syndrome,Oral smecta is superior to gastrolavage for treating much more conveniently,more significant effect and less side effects.

关 键 词：新生儿 咽下综合征 疗效 思密达 

分 类 号：R766.1[医药卫生—耳鼻咽喉科]